nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—kidney cancer—uterine fibroid	0.864	1	CtDrD
Erlotinib—TNK1—nipple—uterine fibroid	0.00222	0.0201	CbGeAlD
Erlotinib—PIP4K2C—nipple—uterine fibroid	0.00173	0.0156	CbGeAlD
Erlotinib—ULK3—nipple—uterine fibroid	0.00165	0.0149	CbGeAlD
Erlotinib—MKNK1—nipple—uterine fibroid	0.00155	0.014	CbGeAlD
Erlotinib—HIPK4—female reproductive system—uterine fibroid	0.00153	0.0139	CbGeAlD
Erlotinib—LTK—female reproductive system—uterine fibroid	0.00152	0.0137	CbGeAlD
Erlotinib—TNK1—uterine cervix—uterine fibroid	0.00148	0.0134	CbGeAlD
Erlotinib—NR1I2—Nuclear Receptors—PGR—uterine fibroid	0.00148	0.0579	CbGpPWpGaD
Erlotinib—PIP4K2C—myometrium—uterine fibroid	0.00148	0.0134	CbGeAlD
Erlotinib—SLK—nipple—uterine fibroid	0.00147	0.0133	CbGeAlD
Erlotinib—TNK1—decidua—uterine fibroid	0.00141	0.0128	CbGeAlD
Erlotinib—ULK3—myometrium—uterine fibroid	0.00141	0.0128	CbGeAlD
Erlotinib—TNK1—urethra—uterine fibroid	0.00136	0.0123	CbGeAlD
Erlotinib—TNK1—endometrium—uterine fibroid	0.00134	0.0121	CbGeAlD
Erlotinib—MKNK1—myometrium—uterine fibroid	0.00133	0.012	CbGeAlD
Erlotinib—AURKC—female reproductive system—uterine fibroid	0.00131	0.0118	CbGeAlD
Erlotinib—TNK1—mammalian vulva—uterine fibroid	0.0013	0.0117	CbGeAlD
Erlotinib—SLK—myometrium—uterine fibroid	0.00126	0.0114	CbGeAlD
Erlotinib—TNK1—uterus—uterine fibroid	0.00124	0.0112	CbGeAlD
Erlotinib—EPHA6—female reproductive system—uterine fibroid	0.00121	0.011	CbGeAlD
Erlotinib—JAK3—female reproductive system—uterine fibroid	0.00121	0.011	CbGeAlD
Erlotinib—EGFR—uterine cervix—uterine fibroid	0.00119	0.0108	CbGeAlD
Erlotinib—NR1I2—Nuclear Receptor transcription pathway—PGR—uterine fibroid	0.00117	0.0458	CbGpPWpGaD
Erlotinib—PIP4K2C—uterine cervix—uterine fibroid	0.00115	0.0104	CbGeAlD
Erlotinib—MAP2K5—nipple—uterine fibroid	0.00114	0.0103	CbGeAlD
Erlotinib—JAK3—female gonad—uterine fibroid	0.0011	0.00997	CbGeAlD
Erlotinib—MAP3K19—female reproductive system—uterine fibroid	0.0011	0.00996	CbGeAlD
Erlotinib—ULK3—uterine cervix—uterine fibroid	0.0011	0.00995	CbGeAlD
Erlotinib—PIP4K2C—decidua—uterine fibroid	0.0011	0.00993	CbGeAlD
Erlotinib—STK10—myometrium—uterine fibroid	0.0011	0.00991	CbGeAlD
Erlotinib—PIP4K2C—urethra—uterine fibroid	0.00106	0.00958	CbGeAlD
Erlotinib—ULK3—decidua—uterine fibroid	0.00105	0.00948	CbGeAlD
Erlotinib—PIP4K2C—endometrium—uterine fibroid	0.00104	0.00943	CbGeAlD
Erlotinib—EGFR—mammalian vulva—uterine fibroid	0.00104	0.00941	CbGeAlD
Erlotinib—MKNK1—uterine cervix—uterine fibroid	0.00104	0.00937	CbGeAlD
Erlotinib—TNK1—female gonad—uterine fibroid	0.00101	0.00916	CbGeAlD
Erlotinib—ULK3—urethra—uterine fibroid	0.00101	0.00915	CbGeAlD
Erlotinib—PIP4K2C—mammalian vulva—uterine fibroid	0.00101	0.00912	CbGeAlD
Erlotinib—TNK1—vagina—uterine fibroid	0.00101	0.0091	CbGeAlD
Erlotinib—ULK3—endometrium—uterine fibroid	0.000995	0.009	CbGeAlD
Erlotinib—EGFR—uterus—uterine fibroid	0.000991	0.00896	CbGeAlD
Erlotinib—MKNK1—decidua—uterine fibroid	0.000986	0.00892	CbGeAlD
Erlotinib—SLK—uterine cervix—uterine fibroid	0.00098	0.00887	CbGeAlD
Erlotinib—MAP2K5—myometrium—uterine fibroid	0.000978	0.00885	CbGeAlD
Erlotinib—PIP4K2C—cardiac atrium—uterine fibroid	0.000965	0.00873	CbGeAlD
Erlotinib—ULK3—mammalian vulva—uterine fibroid	0.000962	0.00871	CbGeAlD
Erlotinib—FLT3—female reproductive system—uterine fibroid	0.000956	0.00864	CbGeAlD
Erlotinib—MKNK1—Signaling mediated by p38-alpha and p38-beta—ESR1—uterine fibroid	0.000954	0.0372	CbGpPWpGaD
Erlotinib—MKNK1—urethra—uterine fibroid	0.000951	0.00861	CbGeAlD
Erlotinib—MKNK1—endometrium—uterine fibroid	0.000936	0.00847	CbGeAlD
Erlotinib—SLK—decidua—uterine fibroid	0.000934	0.00845	CbGeAlD
Erlotinib—ULK3—cardiac atrium—uterine fibroid	0.000922	0.00834	CbGeAlD
Erlotinib—ULK3—uterus—uterine fibroid	0.000917	0.00829	CbGeAlD
Erlotinib—MKNK1—mammalian vulva—uterine fibroid	0.000906	0.00819	CbGeAlD
Erlotinib—SLK—urethra—uterine fibroid	0.000901	0.00815	CbGeAlD
Erlotinib—SLK—endometrium—uterine fibroid	0.000887	0.00802	CbGeAlD
Erlotinib—ABL1—nipple—uterine fibroid	0.00088	0.00796	CbGeAlD
Erlotinib—FLT3—female gonad—uterine fibroid	0.000869	0.00787	CbGeAlD
Erlotinib—MKNK1—cardiac atrium—uterine fibroid	0.000867	0.00785	CbGeAlD
Erlotinib—PIP4K2C—female reproductive system—uterine fibroid	0.000863	0.00781	CbGeAlD
Erlotinib—SLK—mammalian vulva—uterine fibroid	0.000858	0.00776	CbGeAlD
Erlotinib—CYP1B1—Endogenous sterols—CYP17A1—uterine fibroid	0.000854	0.0334	CbGpPWpGaD
Erlotinib—STK10—uterine cervix—uterine fibroid	0.000853	0.00771	CbGeAlD
Erlotinib—ABL2—female gonad—uterine fibroid	0.00083	0.00751	CbGeAlD
Erlotinib—ABL2—vagina—uterine fibroid	0.000825	0.00746	CbGeAlD
Erlotinib—ULK3—female reproductive system—uterine fibroid	0.000824	0.00746	CbGeAlD
Erlotinib—SLK—cardiac atrium—uterine fibroid	0.000821	0.00743	CbGeAlD
Erlotinib—SLK—uterus—uterine fibroid	0.000817	0.00739	CbGeAlD
Erlotinib—STK10—decidua—uterine fibroid	0.000812	0.00735	CbGeAlD
Erlotinib—EGFR—female gonad—uterine fibroid	0.00081	0.00733	CbGeAlD
Erlotinib—NR1I2—Nuclear Receptors—ESR1—uterine fibroid	0.000792	0.0309	CbGpPWpGaD
Erlotinib—PIP4K2C—female gonad—uterine fibroid	0.000785	0.00711	CbGeAlD
Erlotinib—PIP4K2C—vagina—uterine fibroid	0.000781	0.00706	CbGeAlD
Erlotinib—MKNK1—female reproductive system—uterine fibroid	0.000776	0.00702	CbGeAlD
Erlotinib—MAP2K5—uterine cervix—uterine fibroid	0.000761	0.00689	CbGeAlD
Erlotinib—ABL1—myometrium—uterine fibroid	0.000755	0.00683	CbGeAlD
Erlotinib—ULK3—female gonad—uterine fibroid	0.00075	0.00678	CbGeAlD
Erlotinib—STK10—mammalian vulva—uterine fibroid	0.000746	0.00675	CbGeAlD
Erlotinib—ULK3—vagina—uterine fibroid	0.000745	0.00674	CbGeAlD
Erlotinib—MAP2K5—decidua—uterine fibroid	0.000725	0.00656	CbGeAlD
Erlotinib—CYP1B1—Estrogen Receptor Pathway—ESR1—uterine fibroid	0.000713	0.0278	CbGpPWpGaD
Erlotinib—STK10—uterus—uterine fibroid	0.000711	0.00643	CbGeAlD
Erlotinib—MKNK1—female gonad—uterine fibroid	0.000706	0.00639	CbGeAlD
Erlotinib—MKNK1—vagina—uterine fibroid	0.000702	0.00635	CbGeAlD
Erlotinib—MAP2K5—urethra—uterine fibroid	0.0007	0.00633	CbGeAlD
Erlotinib—MAP2K5—endometrium—uterine fibroid	0.000689	0.00623	CbGeAlD
Erlotinib—SLK—female gonad—uterine fibroid	0.000668	0.00605	CbGeAlD
Erlotinib—MAP2K5—mammalian vulva—uterine fibroid	0.000666	0.00603	CbGeAlD
Erlotinib—SLK—vagina—uterine fibroid	0.000664	0.00601	CbGeAlD
Erlotinib—STK10—female reproductive system—uterine fibroid	0.000639	0.00578	CbGeAlD
Erlotinib—MAP2K5—cardiac atrium—uterine fibroid	0.000638	0.00577	CbGeAlD
Erlotinib—NR1I2—Nuclear Receptor transcription pathway—ESR1—uterine fibroid	0.000626	0.0244	CbGpPWpGaD
Erlotinib—ABL1—uterine cervix—uterine fibroid	0.000587	0.00531	CbGeAlD
Erlotinib—STK10—female gonad—uterine fibroid	0.000581	0.00526	CbGeAlD
Erlotinib—STK10—vagina—uterine fibroid	0.000578	0.00523	CbGeAlD
Erlotinib—ABL1—smooth muscle tissue—uterine fibroid	0.000571	0.00516	CbGeAlD
Erlotinib—MAP2K5—female reproductive system—uterine fibroid	0.00057	0.00516	CbGeAlD
Erlotinib—SLCO2B1—decidua—uterine fibroid	0.000564	0.00511	CbGeAlD
Erlotinib—ABL1—decidua—uterine fibroid	0.00056	0.00506	CbGeAlD
Erlotinib—ORM1—endometrium—uterine fibroid	0.000559	0.00506	CbGeAlD
Erlotinib—ABL1—urethra—uterine fibroid	0.00054	0.00488	CbGeAlD
Erlotinib—CYP1A2—nipple—uterine fibroid	0.000534	0.00483	CbGeAlD
Erlotinib—ABL1—endometrium—uterine fibroid	0.000531	0.00481	CbGeAlD
Erlotinib—MKNK1—Signaling by FGFR—TNRC6B—uterine fibroid	0.00053	0.0207	CbGpPWpGaD
Erlotinib—CYP1A1—nipple—uterine fibroid	0.000527	0.00477	CbGeAlD
Erlotinib—MAP2K5—female gonad—uterine fibroid	0.000519	0.0047	CbGeAlD
Erlotinib—MAP2K5—vagina—uterine fibroid	0.000516	0.00467	CbGeAlD
Erlotinib—ABL1—mammalian vulva—uterine fibroid	0.000514	0.00465	CbGeAlD
Erlotinib—SLCO2B1—uterus—uterine fibroid	0.000494	0.00447	CbGeAlD
Erlotinib—MKNK1—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.000493	0.0193	CbGpPWpGaD
Erlotinib—ABL1—cardiac atrium—uterine fibroid	0.000492	0.00445	CbGeAlD
Erlotinib—ABL1—uterus—uterine fibroid	0.00049	0.00443	CbGeAlD
Erlotinib—CYP1B1—smooth muscle tissue—uterine fibroid	0.000483	0.00437	CbGeAlD
Erlotinib—ABCG2—myometrium—uterine fibroid	0.000476	0.00431	CbGeAlD
Erlotinib—CYP1B1—decidua—uterine fibroid	0.000474	0.00429	CbGeAlD
Erlotinib—ORM1—female reproductive system—uterine fibroid	0.000463	0.00419	CbGeAlD
Erlotinib—SLCO2B1—female reproductive system—uterine fibroid	0.000444	0.00402	CbGeAlD
Erlotinib—ABL1—female reproductive system—uterine fibroid	0.00044	0.00398	CbGeAlD
Erlotinib—CYP1A1—Estrogen Receptor Pathway—ESR1—uterine fibroid	0.000439	0.0171	CbGpPWpGaD
Erlotinib—CYP1B1—uterus—uterine fibroid	0.000415	0.00375	CbGeAlD
Erlotinib—SLCO2B1—female gonad—uterine fibroid	0.000404	0.00365	CbGeAlD
Erlotinib—ABL1—female gonad—uterine fibroid	0.0004	0.00362	CbGeAlD
Erlotinib—ABL1—vagina—uterine fibroid	0.000398	0.0036	CbGeAlD
Erlotinib—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000397	0.0155	CbGpPWpGaD
Erlotinib—CYP1B1—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000392	0.0153	CbGpPWpGaD
Erlotinib—CYP1B1—female reproductive system—uterine fibroid	0.000373	0.00337	CbGeAlD
Erlotinib—ABCG2—uterine cervix—uterine fibroid	0.00037	0.00335	CbGeAlD
Erlotinib—ABCG2—decidua—uterine fibroid	0.000353	0.00319	CbGeAlD
Erlotinib—CYP1A1—uterine cervix—uterine fibroid	0.000352	0.00318	CbGeAlD
Erlotinib—CYP2C8—endometrium—uterine fibroid	0.000345	0.00312	CbGeAlD
Erlotinib—CYP3A5—uterine cervix—uterine fibroid	0.000344	0.00311	CbGeAlD
Erlotinib—ABCG2—urethra—uterine fibroid	0.00034	0.00308	CbGeAlD
Erlotinib—CYP1B1—female gonad—uterine fibroid	0.000339	0.00307	CbGeAlD
Erlotinib—ABCG2—endometrium—uterine fibroid	0.000335	0.00303	CbGeAlD
Erlotinib—ABCG2—mammalian vulva—uterine fibroid	0.000324	0.00293	CbGeAlD
Erlotinib—CYP1A1—urethra—uterine fibroid	0.000323	0.00292	CbGeAlD
Erlotinib—CYP1B1—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000322	0.0126	CbGpPWpGaD
Erlotinib—ABCG2—uterus—uterine fibroid	0.000309	0.00279	CbGeAlD
Erlotinib—CYP1A1—mammalian vulva—uterine fibroid	0.000308	0.00278	CbGeAlD
Erlotinib—CYP1A1—cardiac atrium—uterine fibroid	0.000295	0.00267	CbGeAlD
Erlotinib—CYP1A1—uterus—uterine fibroid	0.000293	0.00265	CbGeAlD
Erlotinib—MKNK1—Disease—HPSE2—uterine fibroid	0.000288	0.0112	CbGpPWpGaD
Erlotinib—CYP2C8—female reproductive system—uterine fibroid	0.000285	0.00258	CbGeAlD
Erlotinib—ABL2—Developmental Biology—MED12—uterine fibroid	0.000284	0.0111	CbGpPWpGaD
Erlotinib—CYP1A2—Estrogen Receptor Pathway—ESR1—uterine fibroid	0.00028	0.0109	CbGpPWpGaD
Erlotinib—MAP2K5—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.000269	0.0105	CbGpPWpGaD
Erlotinib—CYP1A1—female reproductive system—uterine fibroid	0.000263	0.00238	CbGeAlD
Erlotinib—EGFR—PI-3K cascade—TNRC6B—uterine fibroid	0.000261	0.0102	CbGpPWpGaD
Erlotinib—CYP1B1—Aryl Hydrocarbon Receptor—ESR1—uterine fibroid	0.000259	0.0101	CbGpPWpGaD
Erlotinib—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000259	0.0101	CbGpPWpGaD
Erlotinib—CYP2C8—vagina—uterine fibroid	0.000258	0.00234	CbGeAlD
Erlotinib—CYP3A5—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000255	0.00996	CbGpPWpGaD
Erlotinib—EGFR—PI3K/AKT activation—TNRC6B—uterine fibroid	0.000255	0.00995	CbGpPWpGaD
Erlotinib—EGFR—GAB1 signalosome—TNRC6B—uterine fibroid	0.000253	0.00987	CbGpPWpGaD
Erlotinib—EGFR—Aryl Hydrocarbon Receptor—ESR1—uterine fibroid	0.000253	0.00987	CbGpPWpGaD
Erlotinib—ABCG2—female gonad—uterine fibroid	0.000253	0.00228	CbGeAlD
Erlotinib—ABCG2—vagina—uterine fibroid	0.000251	0.00227	CbGeAlD
Erlotinib—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—TNRC6B—uterine fibroid	0.000247	0.00965	CbGpPWpGaD
Erlotinib—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000244	0.00954	CbGpPWpGaD
Erlotinib—NR1I2—Generic Transcription Pathway—MED12—uterine fibroid	0.000244	0.00954	CbGpPWpGaD
Erlotinib—CYP1A1—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000241	0.00941	CbGpPWpGaD
Erlotinib—CYP1A1—female gonad—uterine fibroid	0.00024	0.00217	CbGeAlD
Erlotinib—EPHA6—Developmental Biology—MED12—uterine fibroid	0.000239	0.00933	CbGpPWpGaD
Erlotinib—CYP1A1—vagina—uterine fibroid	0.000238	0.00216	CbGeAlD
Erlotinib—ABCB1—myometrium—uterine fibroid	0.000235	0.00212	CbGeAlD
Erlotinib—CYP3A5—female gonad—uterine fibroid	0.000234	0.00212	CbGeAlD
Erlotinib—CYP3A5—vagina—uterine fibroid	0.000233	0.00211	CbGeAlD
Erlotinib—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000224	0.00874	CbGpPWpGaD
Erlotinib—CYP2C8—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000221	0.00863	CbGpPWpGaD
Erlotinib—ABL1—Regulation of Telomerase—ESR1—uterine fibroid	0.000216	0.00845	CbGpPWpGaD
Erlotinib—CYP3A5—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.00021	0.00818	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling by NGF—TNRC6B—uterine fibroid	0.000207	0.00806	CbGpPWpGaD
Erlotinib—NR1I2—Generic Transcription Pathway—PGR—uterine fibroid	0.000202	0.0079	CbGpPWpGaD
Erlotinib—CYP1A1—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000198	0.00773	CbGpPWpGaD
Erlotinib—EGFR—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.000195	0.00762	CbGpPWpGaD
Erlotinib—CYP3A4—female reproductive system—uterine fibroid	0.000193	0.00175	CbGeAlD
Erlotinib—CYP2D6—female reproductive system—uterine fibroid	0.00019	0.00172	CbGeAlD
Erlotinib—EGFR—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.000187	0.00729	CbGpPWpGaD
Erlotinib—EGFR—Regulation of Telomerase—ESR1—uterine fibroid	0.000185	0.00722	CbGpPWpGaD
Erlotinib—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000184	0.00718	CbGpPWpGaD
Erlotinib—EGFR—Signaling by ERBB4—TNRC6B—uterine fibroid	0.000184	0.00718	CbGpPWpGaD
Erlotinib—UGT1A1—Biological oxidations—CYP17A1—uterine fibroid	0.000183	0.00715	CbGpPWpGaD
Erlotinib—ABCB1—uterine cervix—uterine fibroid	0.000183	0.00165	CbGeAlD
Erlotinib—EGFR—Signaling by ERBB4—PGR—uterine fibroid	0.000182	0.0071	CbGpPWpGaD
Erlotinib—CYP2C8—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000182	0.00709	CbGpPWpGaD
Erlotinib—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000182	0.00709	CbGpPWpGaD
Erlotinib—UGT1A1—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000181	0.00705	CbGpPWpGaD
Erlotinib—CYP1A1—PPARA activates gene expression—MED12—uterine fibroid	0.00018	0.00702	CbGpPWpGaD
Erlotinib—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—uterine fibroid	0.000176	0.00687	CbGpPWpGaD
Erlotinib—EGFR—Downstream signal transduction—TNRC6B—uterine fibroid	0.000176	0.00685	CbGpPWpGaD
Erlotinib—EGFR—Signaling by FGFR—TNRC6B—uterine fibroid	0.000175	0.00682	CbGpPWpGaD
Erlotinib—ABCB1—decidua—uterine fibroid	0.000174	0.00157	CbGeAlD
Erlotinib—EGFR—Signaling by ERBB2—TNRC6B—uterine fibroid	0.000174	0.00679	CbGpPWpGaD
Erlotinib—CYP2D6—female gonad—uterine fibroid	0.000173	0.00157	CbGeAlD
Erlotinib—EGFR—DAP12 signaling—TNRC6B—uterine fibroid	0.000173	0.00675	CbGpPWpGaD
Erlotinib—CYP1B1—Biological oxidations—CYP17A1—uterine fibroid	0.000171	0.00667	CbGpPWpGaD
Erlotinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.00017	0.00666	CbGpPWpGaD
Erlotinib—CYP1B1—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000169	0.00658	CbGpPWpGaD
Erlotinib—ABCB1—urethra—uterine fibroid	0.000168	0.00152	CbGeAlD
Erlotinib—ABCB1—endometrium—uterine fibroid	0.000165	0.00149	CbGeAlD
Erlotinib—EGFR—DAP12 interactions—TNRC6B—uterine fibroid	0.000163	0.00635	CbGpPWpGaD
Erlotinib—EGFR—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.000163	0.00635	CbGpPWpGaD
Erlotinib—EGFR—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.000163	0.00635	CbGpPWpGaD
Erlotinib—EGFR—Signaling by EGFR—TNRC6B—uterine fibroid	0.000161	0.0063	CbGpPWpGaD
Erlotinib—EGFR—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00016	0.00624	CbGpPWpGaD
Erlotinib—ABCB1—mammalian vulva—uterine fibroid	0.00016	0.00145	CbGeAlD
Erlotinib—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—uterine fibroid	0.00016	0.00624	CbGpPWpGaD
Erlotinib—EGFR—Signaling by PDGF—TNRC6B—uterine fibroid	0.000159	0.00621	CbGpPWpGaD
Erlotinib—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000156	0.00608	CbGpPWpGaD
Erlotinib—CYP1A2—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000154	0.006	CbGpPWpGaD
Erlotinib—ABCB1—uterus—uterine fibroid	0.000152	0.00138	CbGeAlD
Erlotinib—EGFR—B Cell Activation—TNRC6B—uterine fibroid	0.000151	0.00588	CbGpPWpGaD
Erlotinib—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000149	0.00582	CbGpPWpGaD
Erlotinib—EGFR—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.000144	0.00563	CbGpPWpGaD
Erlotinib—ABCB1—female reproductive system—uterine fibroid	0.000137	0.00124	CbGeAlD
Erlotinib—CYP1A2—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000126	0.00493	CbGpPWpGaD
Erlotinib—ABCB1—female gonad—uterine fibroid	0.000125	0.00113	CbGeAlD
Erlotinib—ABCB1—vagina—uterine fibroid	0.000124	0.00112	CbGeAlD
Erlotinib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—uterine fibroid	0.000121	0.00473	CbGpPWpGaD
Erlotinib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.00012	0.00469	CbGpPWpGaD
Erlotinib—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000119	0.00463	CbGpPWpGaD
Erlotinib—NR1I2—Gene Expression—MED12—uterine fibroid	0.000118	0.00459	CbGpPWpGaD
Erlotinib—ABL1—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.000114	0.00446	CbGpPWpGaD
Erlotinib—CYP3A5—Biological oxidations—CYP17A1—uterine fibroid	0.000111	0.00435	CbGpPWpGaD
Erlotinib—EGFR—Signaling by NGF—TNRC6B—uterine fibroid	0.000111	0.00433	CbGpPWpGaD
Erlotinib—CYP3A5—Metapathway biotransformation—CYP17A1—uterine fibroid	0.00011	0.00429	CbGpPWpGaD
Erlotinib—NR1I2—Generic Transcription Pathway—ESR1—uterine fibroid	0.000108	0.00422	CbGpPWpGaD
Erlotinib—CYP1A1—Biological oxidations—CYP17A1—uterine fibroid	0.000105	0.00411	CbGpPWpGaD
Erlotinib—CYP1A1—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000104	0.00405	CbGpPWpGaD
Erlotinib—MKNK1—Disease—TNRC6B—uterine fibroid	0.000103	0.00402	CbGpPWpGaD
Erlotinib—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine fibroid	0.000102	0.00398	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—MED12—uterine fibroid	0.0001	0.00391	CbGpPWpGaD
Erlotinib—NR1I2—Gene Expression—TNRC6B—uterine fibroid	9.85e-05	0.00384	CbGpPWpGaD
Erlotinib—EGFR—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	9.77e-05	0.00381	CbGpPWpGaD
Erlotinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	9.75e-05	0.00381	CbGpPWpGaD
Erlotinib—NR1I2—Gene Expression—PGR—uterine fibroid	9.75e-05	0.0038	CbGpPWpGaD
Erlotinib—EGFR—Signaling by ERBB4—ESR1—uterine fibroid	9.72e-05	0.00379	CbGpPWpGaD
Erlotinib—CYP2C8—Biological oxidations—CYP17A1—uterine fibroid	9.65e-05	0.00377	CbGpPWpGaD
Erlotinib—CYP2C8—Metapathway biotransformation—CYP17A1—uterine fibroid	9.51e-05	0.00371	CbGpPWpGaD
Erlotinib—EGFR—Disease—HPSE2—uterine fibroid	9.49e-05	0.0037	CbGpPWpGaD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	9.47e-05	0.0037	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—HPSE2—uterine fibroid	8.74e-05	0.00341	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—MED12—uterine fibroid	8.55e-05	0.00334	CbGpPWpGaD
Erlotinib—JAK3—Immune System—TNRC6B—uterine fibroid	8.42e-05	0.00329	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—HPSE2—uterine fibroid	8.15e-05	0.00318	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	8.09e-05	0.00316	CbGpPWpGaD
Erlotinib—CYP2D6—Biological oxidations—CYP17A1—uterine fibroid	7.92e-05	0.00309	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	7.84e-05	0.00306	CbGpPWpGaD
Erlotinib—CYP2D6—Metapathway biotransformation—CYP17A1—uterine fibroid	7.81e-05	0.00305	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—HPSE2—uterine fibroid	7.42e-05	0.0029	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—TNRC6B—uterine fibroid	7.4e-05	0.00289	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—TNRC6B—uterine fibroid	7.22e-05	0.00282	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—PGR—uterine fibroid	7.15e-05	0.00279	CbGpPWpGaD
Erlotinib—CYP1A2—Biological oxidations—CYP17A1—uterine fibroid	6.71e-05	0.00262	CbGpPWpGaD
Erlotinib—CYP1A2—Metapathway biotransformation—CYP17A1—uterine fibroid	6.62e-05	0.00258	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	6.56e-05	0.00256	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—TNRC6B—uterine fibroid	6.32e-05	0.00247	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—TNRC6B—uterine fibroid	6.07e-05	0.00237	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TNRC6B—uterine fibroid	5.44e-05	0.00212	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—PGR—uterine fibroid	5.39e-05	0.0021	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—HPSE2—uterine fibroid	5.31e-05	0.00207	CbGpPWpGaD
Erlotinib—NR1I2—Gene Expression—ESR1—uterine fibroid	5.2e-05	0.00203	CbGpPWpGaD
Erlotinib—CYP3A4—Biological oxidations—CYP17A1—uterine fibroid	5.18e-05	0.00202	CbGpPWpGaD
Erlotinib—CYP3A4—Metapathway biotransformation—CYP17A1—uterine fibroid	5.11e-05	0.00199	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—HPSE2—uterine fibroid	5.02e-05	0.00196	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	4.83e-05	0.00188	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—HPSE2—uterine fibroid	4.6e-05	0.0018	CbGpPWpGaD
Erlotinib—ALB—Metabolism—HPSE2—uterine fibroid	4.58e-05	0.00179	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TNRC6B—uterine fibroid	4.44e-05	0.00173	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	4.43e-05	0.00173	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	4.4e-05	0.00172	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—PGR—uterine fibroid	4.39e-05	0.00171	CbGpPWpGaD
Erlotinib—ABL1—Immune System—TNRC6B—uterine fibroid	4.31e-05	0.00168	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	4.09e-05	0.00159	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	4.04e-05	0.00158	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—HPSE2—uterine fibroid	4.01e-05	0.00157	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—ESR1—uterine fibroid	3.82e-05	0.00149	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—HPSE2—uterine fibroid	3.78e-05	0.00148	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—MED12—uterine fibroid	3.74e-05	0.00146	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	3.7e-05	0.00145	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	3.68e-05	0.00144	CbGpPWpGaD
Erlotinib—EGFR—Immune System—TNRC6B—uterine fibroid	3.68e-05	0.00144	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—MED12—uterine fibroid	3.49e-05	0.00136	CbGpPWpGaD
Erlotinib—EGFR—Disease—TNRC6B—uterine fibroid	3.4e-05	0.00133	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—HPSE2—uterine fibroid	3.2e-05	0.00125	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—MED12—uterine fibroid	3.18e-05	0.00124	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—CYP17A1—uterine fibroid	3.13e-05	0.00122	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	3.08e-05	0.0012	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—CYP17A1—uterine fibroid	2.92e-05	0.00114	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—ESR1—uterine fibroid	2.88e-05	0.00112	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CYP17A1—uterine fibroid	2.66e-05	0.00104	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	2.58e-05	0.00101	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—HPSE2—uterine fibroid	2.47e-05	0.000964	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TNRC6B—uterine fibroid	2.38e-05	0.000929	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PGR—uterine fibroid	2.36e-05	0.00092	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—ESR1—uterine fibroid	2.35e-05	0.000916	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—MED12—uterine fibroid	2.28e-05	0.000888	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—MED12—uterine fibroid	2.15e-05	0.000839	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—MED12—uterine fibroid	1.97e-05	0.000769	CbGpPWpGaD
Erlotinib—ALB—Metabolism—MED12—uterine fibroid	1.96e-05	0.000765	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CYP17A1—uterine fibroid	1.9e-05	0.000744	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CYP17A1—uterine fibroid	1.8e-05	0.000702	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—MED12—uterine fibroid	1.72e-05	0.00067	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CYP17A1—uterine fibroid	1.65e-05	0.000644	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CYP17A1—uterine fibroid	1.64e-05	0.00064	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—MED12—uterine fibroid	1.62e-05	0.000632	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CYP17A1—uterine fibroid	1.44e-05	0.000561	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—MED12—uterine fibroid	1.37e-05	0.000535	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CYP17A1—uterine fibroid	1.35e-05	0.000529	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—ESR1—uterine fibroid	1.26e-05	0.000491	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CYP17A1—uterine fibroid	1.15e-05	0.000448	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—MED12—uterine fibroid	1.06e-05	0.000413	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CYP17A1—uterine fibroid	8.86e-06	0.000346	CbGpPWpGaD
